Latest filing published 02 Oct 2012 for PAR PHARMACEUTICAL COMPANIES, INC., €2.2M.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
All filings by Michael A. Tropiano on record concern PAR Pharmaceutical Companies, Inc. In total, 20 filings cover trades dated from 21 July 2010 to 28 September 2012.
The open-market record is one-sided, with 1 purchase worth €39k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 18 share grants.
The record was last updated on 2 October 2012 with a transaction (€2.2M) in PAR Pharmaceutical Companies, Inc. The last purchase on record was published on 7 September 2011, which is 5,526 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations